Fellowship ​

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.






Professorial Fellow
The University of Melbourne

Professor Mary Galea’s basic and clinical research program has contributed substantially to the global quest to understand how to promote repair, regeneration and recovery of the nervous system after injury. Her seminal contributions to understanding the organisation and response to injury of the corticospinal pathways in animal models have been translated into the development of novel interventions to promote functional recovery after spinal cord injury and other nervous system disorders.

Professor Galea built research capacity in physiotherapy at a time when research in this discipline was sparse. Her sustained academic leadership in her profession has been acknowledged with the award of an Order of Australia.

ResMed Chair in Sleep Medicine
The University of Sydney

Professor Peter Cistulli is recognised nationally and internationally as a clinical and research leader in the field of Respiratory and Sleep Medicine. He has made major contributions to the understanding of the causes and treatment of common sleep disorders, such as Obstructive Sleep Apnoea (OSA). His pioneering work on novel therapies, and particularly oral appliances for the treatment of OSA, has changed clinical practice in the field and has contributed to the development of a new interdisciplinary field of Dental Sleep Medicine, bridging medicine and dentistry.

Through distinguished contribution to clinical practice, research and teaching, Professor Cistulli has advanced his field.

Professor of Ophthalmology
Lions Eye Institute

Professor Ian Constable is an internationally recognised clinical and research ophthalmologist. As the Founding Director of the Lions Eye Institute, he created a not-for-profit centre of excellence that combines world-class scientific research into the prevention of blindness with the highest level of eye care delivery. He has trained and mentored almost 100 clinical and research Fellows from all over the world and has provided an environment to conduct research at the highest international standards.

Professor Constable’s work has been instrumental in some significant developments in ophthalmology, including an artificial cornea and a first in human gene therapy trial for exudative Macular Degeneration.


Scientia Professor
UNSW Sydney

Professor Guy Marks is a world-leading respiratory physician and epidemiologist, whose outstanding contributions to the fields of asthma, chronic lung disease, tuberculosis (TB) and air pollution have transformed the national and global responses to these health problems. His sustained research through the Woolcock Institute of Medical Research has been recognised by major awards from the NHMRC, the Thoracic Society, the Ingham Institute and UNSW Sydney.

Professor Marks has made important contributions to training and policy development in lung health and TB control in Australia and internationally. His sustained leadership within the International Union Against TB and Lung Diseases led to his appointment as President in 2019.

Senior Group Leader
The Francis Crick Institute

Professor Carola Vinuesa’s research has contributed to understanding the pathogenesis of autoimmune diseases. She defined the nature of T cell help for B-cells, establishing that follicular helper T (TFH) cells, rather than TH2-cells, are required for antibody production. She also discovered that TFH dysregulation causes autoimmunity, and that TFH cell function is modulated by a unique subset of regulatory T-cells: TFR cells. More recently she uncovered an important role for rare coding gene variants in human systemic autoimmunity.

Professor Vinuesa’s TFH/TFR discoveries are being translated into improving vaccination, eliminating HIV reservoirs, preventing transplant rejection, and treating autoimmunity, immunodeficiency, cancer and allergies.

Consultant Medical Oncologist and Group Leader, Cancer Biology and Therapeutics Program; Professor, Centre for Cancer Research, University of Melbourne
Peter MacCallum Cancer Centre

Professor Sarah-Jane Dawson is a clinician scientist who has consistently demonstrated excellence, leadership and dedicated service to health and medical research in Australia. Professor Dawson’s research has pioneered fundamental advances in the clinical application of cancer genomics and the development of personalised biomarker approaches using circulating tumour DNA. This body of work has led to the rapid expansion of research in this field and established a new paradigm for molecular disease monitoring in cancer.

Professor Dawson continues to demonstrate an ongoing commitment to advancing healthcare through the translation of her discoveries into the clinical arena to improve survival outcomes for cancer patients.

Chair of Clinical Pharmacology
The University of Newcastle

Professor Jennifer Martin is dual-trained clinical pharmacologist and physician based in Newcastle. Through combining her clinical practice with a strong program of research, she has driven clinical impact through knowledge translation and informing effective government policy and regulation with evidence-based research. Her research spans the full translational pathway, from discovery and animal development work, to Phase I-IV clinical trials, and implementation of research into the therapeutic setting.

Professor Martin is considered a leader in her field and is an expert advisor to the health and pharmaceutical sector, industry and various governments, particularly in the area of drug development and pharmaceutical regulation.

Director of Neurophysiology
Westmead Hospital

Professor Steve Vucic is a clinical academic and internationally recognised researcher in the field of neuroscience with an emphasis on understanding amyotrophic lateral sclerosis (ALS) pathogenesis. His key discoveries relating to identification of “cortical hyperexcitability” as an important pathophysiological mechanism in ALS have transformed the understanding of ALS, resulted in novel therapeutic approaches and led to development of pharmacodynamic biomarkers. In addition, a much-needed diagnostic investigation was developed for ALS, termed threshold tracking transcranial magnetic stimulation (TMS), enabling earlier diagnosis and thereby recruitment into clinical trials.

Professor Vucic has published and presented extensively and has received national and international accolades for his research.

NHMRC Principal Research Fellow
The University of Sydney

Professor Kirsten McCaffery is a highly productive academic with exceptional research output and impact for a behavioural scientist working in public health, with over 230 publications and impact on national and international policy and practice.

Professor McCaffery has shown leadership in the establishment of the Sydney Health Literacy Lab, in Wiser Healthcare, and as Director of Research at the University of Sydney School of Public Health. Her work has had a sustained impact on policy and practice in the areas of cancer screening, health literacy and overdiagnosis and attracted significant media attention to promote understanding of medical science in the community.



Research Director, Genomics and Epigenetics Division
Garvan Institute of Medical Research

Professor Susan Clark is a worldwide pioneer in the field of cancer epigenetics. Her research revolutionised the field through her pivotal contribution to advancements in new technologies for profiling DNA methylation changes in early development and cancer. Her current research involves understanding the 3D epigenetic landscape of large‐scale domains in cancer, and developing new genome‐wide sequencing and bioinformatic protocols to map DNA methylation, histone modifications and regulatory RNA profiles.

Professor Clark’s team has recently demonstrated that epigenetic changes in cancer encompass large genome‐wide domains, resulting in global and coordinated gene silencing and activation, which provide new insights for disease diagnosis and treatments.

About Fellowship with AAHMS

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

To ensure the Academy has a representative and diverse membership, Fellows nominating two new candidates are asked to include only a maximum of one man, and Fellows nominating four new candidates are asked to include only a maximum of two men.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.